Prognostic significance of serum lactate following cardiac transplantation

Biomark Med. 2022 Jun;16(8):599-611. doi: 10.2217/bmm-2021-1041. Epub 2022 Mar 24.

Abstract

Aim: Hyperlactatemia is common post-heart transplantation. Lactate measurements in the first 24 h were analyzed with respect to mortality. Methods: A total of 153 consecutive cardiac transplant patients were reviewed. Recipients of organs maintained in a state of ex vivo perfusion were included. Results: A total of 143 heart recipients were included. Hyperlactatemia (>2 mmol/l) was present in all patients. Despite maximum lactate and lactate clearance being significantly higher in nonsurvivors (p = 0.002, p = 0.004), neither receiver operator curve analysis nor multivariate logistic regression showed association with 1-year mortality. In comparison, the minimum lactate was significantly associated with mortality (area under the curve 0.728 [p < 0.001]; odds ratio 1.28 [95% 1.01-162; p = 0.04]). Conclusion: The minimum lactate, a surrogate of persistent hyperlactatemia, was demonstrated to be superior compared with maximum lactate and lactate clearance in determining patient prognosis.

Keywords: ex vivo perfusion; heart transplant; hyperlactatemia; lactate clearance.

MeSH terms

  • Heart Transplantation* / adverse effects
  • Humans
  • Hyperlactatemia*
  • Lactic Acid
  • Prognosis
  • Retrospective Studies

Substances

  • Lactic Acid